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MuscleTelomerase reverse transcriptase (TERT) is a key component of the telomerase complex. By lengthening telo-
meres in DNA strands, TERT increases senescent cell lifespan. Mice that lack TERT age much faster and exhibit
age-related conditions such as osteoporosis, diabetes and neurodegeneration. Accelerated telomere shortening
in both human and animalmodels has been documented in conditions associatedwith insulin resistance, includ-
ing T2DM. We investigated the role of TERT, in regulating cellular glucose utilisation by using the myoblastoma
cell line C2C12, as well as primary mouse and human skeletal muscle cells. Inhibition of TERT expression or
activity by using siRNA (100 nM) or speciﬁc inhibitors (100 nM) reduced basal 2-deoxyglucose uptake by
~50%, in all cell types, without altering insulin responsiveness. In contrast, TERT over-expression increased
glucose uptake by 3.25-fold. In C2C12 cells TERT protein was mostly localised intracellularly and stimulation of
cells with insulin induced translocation to the plasma membrane. Furthermore, co-immunoprecipitation exper-
iments in C2C12 cells showed that TERTwas constitutively associatedwith glucose transporters (GLUTs) 1, 4 and
12 via an insulin insensitive interaction that also did not require intact PI3-K and mTOR pathways. Collectively,
these ﬁndings identiﬁed a novel extra-nuclear function of TERT that regulates an insulin-insensitive pathway
involved in glucose uptake in human and mouse skeletal muscle cells.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Ageing is an established risk factor for the development of the met-
abolic syndrome and type 2 diabetes (T2DM). At the cellular level, se-
nescence and ageing are associated with a decrease in telomere length
and accelerated telomere shortening has been documented in condi-
tions associated with insulin resistance, including T2DM [1–3]. Mainte-
nance of telomere length is dependent on the activity of the enzyme
telomerase and in particular its catalytic protein TERT (telomerase re-
verse transcriptase), which can help reverse this process and extend
the lifespan of cells [4,5]. Models of metabolic disorders have provided
further evidence for a role of TERT in glucose metabolism; for example,
mononuclear cells of diabetic patients display accelerated telomere
shortening in comparison to age-matched healthy individuals, an effect
correlated with poor glycaemic control [6,7]. Furthermore telomere
shortening in the β-cells of mice has also been found to impair insulinLaboratories, Warwick Medical
lands CV2 2DX, UK. Tel.: +44
aheen),
s),
rwick.ac.uk (V.A. Zammit),secretion thus leading to glucose intolerance even though there was
an intact number ofβ-cell numbers, and so demonstrating a role of telo-
meres in the pathogenesis of diabetes [8].
In cells TERT shuttles between the nucleus and the cytoplasm [9–11].
Nuclear TERT regulates telomere length by catalysing addition of repet-
itive tandem (TTAGGG) DNA sequences to telomeres, therebymonitor-
ing cell turnover and maintaining telomere length [12–14]. Recently
TERT has been identiﬁed in mitochondria [10], where it appears to pro-
tect mitochondrial DNA and function from damage induced by oxida-
tive stress, thus preventing apoptosis and promoting cell survival [11,
15–17].
Sincemitochondrial function is closely associatedwith cellular fuel se-
lection, we hypothesised that extra-nuclear functions of TERT may target
the signalling pathways controlling glucose utilisation [18,19]. Previous
in vivo studies showed that telomerase deﬁciency impairs glucosemetab-
olism and insulin secretion [20]. The availability of glucose itself has
also been shown to have a direct effect on the epigenetic modulation of
TERT, resulting in the modulation of cell lifespan [21]. In addition, TERT
possesses a consensus sequence on Ser824 for phosphorylation by Akt,
which leads to increased activity [22–24], whereas inhibition of PI3K
activity reduces both TERT phosphorylation by Akt and nuclear transloca-
tion, resulting in decreased nuclear telomerase activity [25,26]. This raises
the possibility that insulin may acutely affect the cytosolic functions
of TERT.
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stimulated glucose uptake activity in cells with altered TERT expression
or activity using mouse muscle-derived C2C12 as well as human and
primary mouse skeletal muscle cells. In addition, we have studied the
intracellular distribution of TERT protein in response to insulin in
C2C12 cells. We ﬁnd that basal but not insulin-stimulated glucose up-
take requires adequate TERT expression and identiﬁed a novel interac-
tion between TERT and the glucose transporters GLUT1, 4 and 12.
2. Materials and methods
2.1. Ethics statement
The experimental protocols for the animals were in accordancewith
the United Kingdom Animal (Scientiﬁc Procedures) Act of 1986 (ASPA).
AHomeOfﬁce project licencewas not required for this study because no
regulated procedures were carried out. Mice were humanely sacriﬁced
by CO2 asphyxiation, which is an appropriate method under Schedule
1 of the Act.
2.2. Cell culture
2.2.1. C2C12
The C2C12mousemyoblast cells (American Type Culture Collection,
ATCC) were maintained in DMEM (Invitrogen, Paisley, UK) supple-
mented with 5 mM glucose and 10% FCS (BioSera, Sussex, UK) at
37 °C in 5% CO2.
2.2.2. Human skeletal muscle cells
The human skeletal muscle cells (PromoCell, UK Human Cell Culture
Systems)were cultured in skeletal muscle growthmediumprovided by
the supplier supplemented with 5% FCS, fetuin (50 μg/ml), basic ﬁbro-
blast factor (1 ng/ml), epidermal growth factor (10 ng/ml), insulin
(10 μg/ml) and dexamethasone (0.4 μg/ml) at 37 °C in 5% CO2.
2.2.3. Primary mouse skeletal muscle cells
The primary mouse skeletal muscle cells were isolated from 3–
7week oldmale BLaC6mice.Micewere sacriﬁced, and the gastrocnemi-
us and soleusmuscles were pooled, cut along the ﬁbres and digested for
25 min at 37 °C in oxygenated collagenase (1.5 mg/ml, Worthington
Biochemicals, Lorne Laboratories, Reading, UK) solution. Cells were iso-
lated as previously described [27], and kept in DMEM supplemented
with 5 mM glucose, 5% FCS and 1% penicillin/streptomycin solution
(Sigma Aldrich, Dorset, UK) at 37 °C in 5% CO2.
2.3. Pharmacological inhibitors
TERT activity was inhibited using several pharmacologically ac-
tive agents, namely triethylene tetraamine (TETA, Fisher Scientiﬁc,
Loughborough, UK), geldanamycin (GA, Alexis Biochemicals, Enzo Life
Sciences, Exeter, UK) and 17-(allylamino)-17-demethoxygeldanamycin
(17-AAG, Sigma Aldrich). On the day of treatment, the required agents
were added to the cell culture medium at various concentration(s)
(1–100 nM; unless otherwise stated). Cells were incubated with the
inhibitors for 1–24 h prior to measurement of the biological effect(s).
2.4. Transfection of cells with TERT and siRNA
The TERT-pBABE-puro construct was kindly provided by DrWoody E.
Wright (University of Texas). Pre-designed siRNA for human and mouse
TERT was obtained from Dharmacon (Thermo Scientiﬁc, Loughborough,
UK). Cells were subcultured into 12-well culture plates for 24 h prior to
transfection with increasing concentrations of either TERT plasmid or
50–500 nM siRNA using Lipofectamine 2000 (Invitrogen) according to
themanufacturer's instructions. Empty pBABE-puro construct and scram-
bled siRNA (Ambion Applied Biosystems, Warrington, UK) were used ascontrols. During the optimisation phase of the methodology, signiﬁcant
reduction of cell viability was observed when the concentration of
siRNA heteroduplexes exceeded 200 nM (data not shown) and for that
reason a concentration of 100 nM siRNAwas employed in all subsequent
experiments.
2.5. 2-Deoxyglucose uptake assay
2-Deoxyglucose uptake measurements were carried out as de-
scribed previously, for 10 min in glucose-free DMEM supplemented
with 0.1% BSA containing 20 μM 2-[3H]-deoxy-D-glucose (0.53 μCi/ml,
AmershamGEHealth, Buckinghamshire, UK) in the absence or presence
of insulin and inhibitors, unless otherwise stated [28]. Non-carrier
mediated uptake was determined in parallel in the presence of 10 μM
cytochalasin B (Alexis Biochemicals) and the values subtracted from
the total uptake per assay.
2.6. Immunoﬂuorescence staining and confocal microscopy
Cells were grown on cover-slips and treated as required. They were
subsequently ﬁxed using 4% paraformaldehyde, permeabilised with
0.1% Triton X-100 and blocked for 1 h in 5% goat serum and BSA. Cells
were stained with anti-TERT antibody (1:200, Novus Biologicals,
Cambridge, UK), anti-GLUT1 (1:100, Abcam, Cambridge, UK), anti-
GLUT4 (1:100, Abcam) and anti-GLUT12 (1:100 [29]) and detected
using (1:400) AlexaFluor® 488 goat anti-rabbit ﬂuorescent secondary
antibody (Invitrogen). Samples were mounted in media containing
DAPI (Vector Labs, Peterborough, UK). Negative controls were run
with secondary antibody alone to exclude any non-speciﬁc binding/
autoﬂuorescence. Images were acquired with an AxioVert 200M laser
scanning confocal microscope under either a 20 × x or 40–63 × 1.4 NA
oil immersion objective. Images were captured using a Carl Zeiss laser
scanning microscope and LSM 510 imaging software. Fluorescence in-
tensity proﬁles were generated along multiple line axes, analysed, and
quantiﬁed using ImageJ software developed at the National Institutes
of Health (http://rsb.info.nih.gov/ij/). Quantiﬁcation was carried out
on thirty cells from randomly chosen ﬁelds (n = 3) for each condition.
Both paired region of analysis and region of interest were used to mon-
itor changes in protein intracellular distribution.
2.7. Western blotting
Cell protein extracts were resolved by SDS-PAGE (10%). The proteins
were transferred onto nitrocellulose membrane and immunoblotted
with the appropriate antibody and detected using chemiluminescence
substrate (SuperSignal West Pico, Thermo Scientiﬁc, UK).
2.8. Immunoprecipitation
Cells were lysed in ice-cold lysis buffer (20 mM HEPES, 500 mM
NaCl, 25 mM DTT, 20% glycerol and 0.1% NP-40, and supplemented
with 1:100 protease and phosphatase inhibitor cocktails). The extracts
were incubated with each antibody and 15 μl of protein G-beads
(Millipore, Watford, UK), and the immunoprecipitates subjected to
SDS-PAGE.
To ensure use of equal amounts of protein per sample, blots were
performed before immunoprecipitation experiments using β-actin
(data not shown).
2.9. Statistical analysis
Values are represented as themeans± SEM, for the number of inde-
pendent experiments indicated in the legends of the ﬁgures. Data were
tested for homogeneity and comparison betweengroupmeanswasper-
formed by two-tailed Student's t-test with Prism software (v. 5.03,
1764 F. Shaheen et al. / Biochimica et Biophysica Acta 1842 (2014) 1762–1769GraphPad Software). Signiﬁcant difference among different treatment
groups was denoted by p b 0.05.
3. Results
3.1. Expression characteristics of TERT in C2C12
In preliminary experimentswe investigated the expression and sub-
cellular localisation characteristics of TERT in C2C12 myoblasts. Using
RT-PCR we detected signiﬁcant levels of TERT mRNA; furthermore
these cells express a protein with a molecular mass of 120 kDa recog-
nized by a speciﬁc TERT antibody (data not shown). We also used indi-
rect immunoﬂuorescent signal detection by confocal microscopy to
investigate TERT expression characteristics. As previously described
[30], in cells such as R-cells (L5178Y murine lymphoma cell line) that
possess very long telomeres (~48 kb), TERT is highly expressed and ex-
clusively localised in the nucleus. By contrast, in C2C12 cells, we detect-
ed a different expression pattern; under unstimulated conditions, basal
TERT immunostaining was distributed diffusely throughout the cyto-
plasm with only weak signal in the nucleus, raising the possibility of
extra-nuclear actions of TERT in these cells (Fig. 1a).
C2C12 cells respond to insulin actions via an extensive signalling
network that involves activation of the PI3-K and mTOR signalling
cascades [31–34]. Exposure of C2C12 cells to insulin (100 nM for 1 h) in-
duced TERT intracellular movement evident from increased TERT signal
redistribution near or at the plasmamembrane by 35% (Fig. 1b). Similar
experiments were repeated in C2C12 cells engineered to overexpress
exogenous TERT (C2C12-TERT). These cells expressed 5–7 fold higher(a) 
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Fig. 1. Confocal micrographs of C2C12 cells immunostained for endogenous TERT protein a
immunostained for endogenous TERT using an Alexa-Fluor® 488 (green) secondary antibody
TERT protein. c) C2C12 cells were transfected with 2 μg TERT plasmid and subsequently treate
h and then insulin for 10 min and after 24 h immunostained for TERT protein. Cell nuclei wer
(C2C12 cells at 63× objective). Micrographs are representative of three separate experiments
ﬂuorescent intensity and change in protein distribution were determined by measuring paire
the nucleus and cytoplasm by deﬁning a cross-sectional area and plotting proﬁles of ﬂuoresc
from 30 random cells (n = 3). Values presented are mean (±SEM) of 3 independent expe
samples: **p b 0.01 and ***p b 0.001.levels of TERT compared to native C2C12 cells (data not shown) and im-
munoﬂuorescent signal detection showed that plasmid transfection re-
sulted in a signiﬁcant increase in TERT signal without any changes in
subcellular localisation characteristics with the majority of the intracel-
lular signal detected in the cytoplasm but not the nucleus (Fig. 1c). Ex-
posing these cells to insulin led in a 2-fold increase in TERT signal
translocated near or at the plasma membrane compared to control
untreated cells. Insulin actions required intact PI3-K and mTOR activity
since pre-treatment of C2C12-TERT cells with either wortmannin or
rapamycin abolished insulin effect on TERT translocation (Fig. 1d).3.2. TERT co-localises with GLUTs in C2C12 cells
The insulin-regulated localisation of TERT in C2C12 prompted us to
study potential interactions between TERT and GLUTs, which represent
major targets of insulin in the control of glucose uptake by skeletalmus-
cle cells. Preliminary RT-PCR experiments using sequence-speciﬁc
primers for GLUT1, GLUT4 and GLUT12 ampliﬁed DNA fragments for
each GLUT in both undifferentiated and differentiated C2C12myoblasts
(Fig. 2a). Moreover, immunostaining experiments using speciﬁc anti-
bodies detected strong immunoﬂuorescent signal for each of the three
GLUTs in C2C12 cells (Fig. 2b). Similar to other cell types [35–37], the
housekeeping transporter GLUT1 signal was detected in both cytoplasm
and plasma membrane, whereas GLUT4 and GLUT12 staining was pri-
marily in the cytoplasm. Insulin treatment of C2C12 cells led to signiﬁ-
cant redistribution of GLUT4 and GLUT12 signal; however although
GLUT4 signal showed the expected translocation to the cell surface,0 
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ent intensity across that area. Data is representative for ﬂuorescent intensities averaged
riments. Asterisks indicate statistical signiﬁcance (t-test) of difference from control
(a)
(b)
Fig. 2. Glucose transporter 1, 4 and 12 mRNA expression in C2C12 and confocal micrographs of C2C12 cells showing immunostaining of GLUT1, 4 and 12 in the presence and absence of
insulin. a) Graphs show themRNA expression of GLUTs 1, 4 and 12 in undifferentiated (U) and differentiated (D) C2C12 cells. Reverse transcription PCR (RT-PCR) was performed on RNA
extracted from treated cells. GAPDHmRNAwasused as an internal control and an image of the gelwas captured and used to quantify GLUTmRNAexpression using ImageJ software. C2C12
cells immunostained for endogenous b) GLUT1, GLUT4 and GLUT12 proteins. Cells were treatedwith 100 nM insulin for 1 h and immunostained. Cells were imaged using an Alexa-Fluor®
488 (green) secondary antibody. Cell nuclei were respectively stainedwith DAPI (blue) and images captured using confocal microscopy. Micrographs are representative of three separate
experiments. Images were analysed for changes in protein localisation between the nucleus and cytoplasm by deﬁning a cross-sectional area and plotting proﬁles of ﬂuorescent intensity
across that area.
1765F. Shaheen et al. / Biochimica et Biophysica Acta 1842 (2014) 1762–1769GLUT12 signal was localised to peri-nuclear structures that were also
stained by an antibody against a Golgi marker (Fig. 2b).
The possibility of direct interaction between TERT and GLUTs was
further investigated in C2C12 cells. Co-immunoprecipitation studies
with an anti-TERT antibody in whole cell extracts identiﬁed a constitu-
tive association between TERT and all three glucose transporters
(GLUT1, GLUT4 and GLUT12). Under insulin stimulated conditions,
TERT association with GLUT12 but not GLUTs 1 and 4 was enhanced
by insulin stimulation. However, basal or insulin-induced interaction
appeared to be independent of PI3-K and mTOR activity since pre-
treatment of cells with either wortmannin or rapamycin had no effect
on TERT–GLUT associations (Fig. 3). In addition, TETA a telomerase in-
hibitor did not affect TERT association with GLUT1, GLUT4 and GLUT12.
Interestingly, exposure of C2C12 cells to geldanamycin (which inhibits
TERT through inhibition of thehsp90–TERT complex formation) appearedto reduce the amount of GLUT12 co-immunoprecipitated by the
TERT antibody, without altering immunoprecipitated GLUT1 and
GLUT4 levels.
3.3. TERT and 2-deoxyglucose (2-DG) uptake in C2C12
The studies described above raised the possibility that TERT is
involved in the regulation of glucose uptake in skeletal muscle cells.
This was investigated in C2C12 myoblasts by a 2-DG uptake assay;
unstimulated cells exhibited signiﬁcant 2-DG uptake (71 ± 5 pmol/
10 min/mgprotein). In agreementwith previous studies [36] treatment
with insulin (100 nM) for 10min signiﬁcantly increased 2-DGuptake by
44% compared to non-treated cells. To test the effect of TERT on basal
glucose uptake, we employed knock-down of TERT expression by
short interfering RNA sequences complementary to the TERT transcript.
(b)
(a)
Fig. 3.Association of TERT proteinwith GLUT1, GLUT4 and GLUT12 proteins in C2C12 cells and the effect of inhibitors on this interaction. C2C12 cell lysateswere immunoprecipitatedwith
TERT antibody and probed for GLUT1, GLUT4 andGLUT12 proteins in control cells and in cells incubatedwith 100 nM insulin. C2C12 cell lysateswere prepared from control cells and cells
treatedwith 100 nM rapamycin (for 24 h), wortmannin (1 h), geldanamycin or TETA (24 h). 20 μg of each cell lysate was immunoprecipitatedwith TERT antibody and probed for GLUT1,
GLUT4 and GLUT12 proteins. Protein G beadswere used as a control. β-Actin probing before IPwas used as a loading control. Results are representative of three independent experiments
(IP: immunoprecipitation and WB: western blotted).
1766 F. Shaheen et al. / Biochimica et Biophysica Acta 1842 (2014) 1762–1769Preliminary experiments (Fig. 4a) demonstrated that at a concentration
of 100 nM, speciﬁc siRNA effectively reduced TERTmRNA expression by
40–50% and protein by 80–90% in C2C12 cells. In contrast, transfection
of cells with random sequence siRNA had no effect on TERT expression.
Knock-downof TERT expression in the C2C12 cells using siRNA result-
ed in a signiﬁcant reduction in basal 2-DG uptake by approximately 20%
(Fig. 4b). The difference in the efﬁciency of the siRNA to down-regulate
mRNA and protein expression may reﬂect the manner in which siRNA
targets mRNA and interferes with its degradation and therefore the im-
pact on the linked but independent gene transcription and subsequent
protein translation could be quite different. Cell viability assays conﬁrmed
that this inhibitory effect did not result from increased cell death (Fig. 4c).
Using a complementary approachwe also investigated the effects of TERT
inhibitors; all inhibitors tested (geldanamycin, 17-AAG and TETA) signif-
icantly decreased basal 2-DG uptake in C2C12 cells by varying degrees of
potency of 32–71%. Interestingly, we also observed inhibitory effects be-
tween 27 and 55% of these compounds on TERTmRNA expression raising
the possibility that their action might involve regulation of TERT tran-
scription (Fig. 4d). The inhibitory effects of siRNA or chemical TERT inhib-
itors were not due to non-speciﬁc toxic effects of these inhibitors as both
cell viability (Fig. 4c) and total cell protein remained unchanged.
Follow-up experiments investigated also the effect of TERT over-
expression on basal 2-DG uptake in C2C12-TERT cells. In these cells, in-
creased intracellular TERT expression led to a 53% increase in basal 2-DG
uptake (Fig. 5).Since our previous experiments identiﬁed insulin-dependent regu-
lation of TERT intracellular localisation, we next investigated whether
TERT was involved in insulin induced glucose transport. Although
maximal stimulation was attenuated in TERT inhibitor-treated cells, in-
sulin effect on 2-DG uptake was comparable between TERT inhibitor-
treated and control cells (Fig. 6a) suggesting that TERT inhibition does
not affect the ability of insulin to stimulate glucose transport. Moreover,
insulin effects were not affected by TERT knocked-down or overexpres-
sion (data not shown) conﬁrming independence from TERT expression
levels.
To investigate whether TERT effects were cell type speciﬁc, we
carried out similar experiments in primary mouse skeletal muscle
cells and in human muscle cells. In both types of cells overexpression
of TERT increased basal 2-DG uptake by 3–3.5 fold but did not affect
the magnitude of insulin responses, suggesting a similar mode of TERT
actions in these cells (Fig. 6b). Moreover, silencing TERT mRNA expres-
sion by siRNA in both human and primary mouse skeletal muscle cells
reduced the basal rate of glucose uptake by 37% and 43% respectively
(Fig. 6c), but did not alter insulin effects (data not shown).
4. Discussion
The present work identiﬁed a novel extra-nuclear function of TERT
that contributes in the regulation of basal glucose transport in C2C12
myoblasts. Similar ﬁndings in human and primary mouse skeletal
(a) (b) 
(c) 
(d) 
Fig. 4. Effect of TERT siRNA and inhibitors on [3H] 2-deoxyglucose uptake and TERT mRNA and protein expression in C2C12 cells. The effect of TERT siRNA on a) TERTmRNA and protein
expression was assessed. C2C12 cells were transfected with 100 nM TERT siRNA and random siRNA (as control) and analysed 24 h after transfection. Reverse transcription PCR (RT-PCR)
was performedonRNAextracted from treated cells. GAPDHmRNAwas used as an internal control and an image of the gelwas captured and used to quantify TERTmRNA expression using
ImageJ software. Western blotting was performed to analyse TERT protein expression and β-actin was used as a loading control. b) The effect of TERT knock-down on 2-deoxyglucose
uptake was assessed; cells were transfectedwith 100 nM TERT siRNA. Random siRNAwas used as a negative control and cells were analysed 24 h after transfection. Cells were incubated
in serum free medium for 4 h and 2-deoxyglucose uptake was measured over 10min and is represented as pmol/10 min/mg protein. c) The effect of 100 nM TERT siRNA, random siRNA
and transfection reagent (Lipofectamine) on cell viability was assessed usingMTT assay. d) Reverse transcription PCR (RT-PCR)was performed on RNA extracted from C2C12 cells treated
with 100 nM TETA, geldanamycin or 17-AAG for 24 h. GAPDHmRNA was used as an internal control and an image of the gel was captured and used to quantify TERT mRNA expression
using ImageJ software. Values are means (±SEM) for 5 separate experiments, performed in duplicate. Asterisks indicate statistical signiﬁcance (t-test) of difference from
control: *p ≤ 0.05, **p b 0.01 and ***p b 0.001.
Fig. 5. Effect of TERT over-expression on [3H] 2-deoxyglucose uptake in C2C12 cells. The
effect of TERT over-expression on 2-deoxyglucose uptake was assessed; C2C12 cells
were transfected with pBABE-puro-TERT plasmid (6 μg). Lipofectamine and empty
pBABE-puro plasmid (control vector) were used as negative controls. After 24 h the cells
were incubated in serum free medium for 4 h and 2-deoxyglucose uptake was measured
over 10 min. 2-Deoxyglucose uptake is represented as pmol/10 min/mg protein. Values
presented are means (±SEM) for 5 separate experiments, performed in duplicate. Aster-
isk indicates statistical signiﬁcance (t-test) of difference from control: *p ≤ 0.05.
1767F. Shaheen et al. / Biochimica et Biophysica Acta 1842 (2014) 1762–1769muscle cells provide further support for the physiological relevance of
TERT actions. Muscle cells take up ~65% of the glucose produced by
the liver in the basal, low-insulin concentration, and are responsible
for 80% of the insulin-stimulated glucose disposal. To exert this action
skeletal muscle TERT is primarily localised outside the nucleus, in the
cytoplasm and its subcellular localisation and trafﬁcking to the cell sur-
face appear to be regulated by the insulin signalling machinery, in par-
ticular the mTOR and PI3-K cascades. At present the functional
consequences of TERT–insulin interactions are unknown but our studies
suggest that it is unlikely to involve regulation of insulin-induced glu-
cose uptake, a mechanism which is not affected by changes in TERT
expression.
One potential mechanism that would allow TERT to regulate basal
glucose uptake might involve protein–protein interactions with the
various glucose transporters,which contributes to basal aswell as extra-
cellular signal-stimulated glucose uptake, such as the GLUT1, GLUT4
and GLUT12, as indicated by their co-immunoprecipitation with TERT
in unstimulated C2C12 cells. TERT–GLUT interaction appears to be inde-
pendent of insulin signalling mediators such as mTOR and PI3-K activi-
ty. To date, several GLUT-binding proteins have been identiﬁed [36],
including aldolase and α-actinin 4 which may work as scaffolds linking
GLUT to actin cytoskeleton or other speciﬁc intracellular anchors
(b) 
(c) 
(a) 
Fig. 6. Effect of TERT inhibition in C2C12 cells and over-expression and knock-down on [3H] 2-deoxyglucose uptake in human and primarymouse skeletal muscle cells. The effect of TERT
inhibition on 2-deoxyglucose uptakewas assessed in: a) C2C12 cells treatedwith 100 nMgeldanamycin (GA), TETA or 17-AAG for 24 h and then 100 nM insulin for 10min. b) Human and
primary mouse skeletal muscle cells were transfected with 4 μg and 6 μg pBABE-puro-TERT plasmid, respectively. Lipofectamine and empty pBABE-puro plasmid (control vector) were
used as negative controls. c) Next the effect of TERT knock-down on 2-deoxyglucose was assessed. Primary mouse and human skeletal muscle cells were transfected with 100 nM
TERT siRNA and random siRNA was used as a negative control. After 24 h the cells were incubated in serum free medium for 4 h and 2-deoxyglucose uptake was measured over
10min. 2-Deoxyglucose uptake is represented as pmol/10 min/mgprotein. Values aremeans (±SEM) for 4 independent experiments, performed in duplicate. Asterisks indicate statistical
signiﬁcance (t-test) of difference from control: *p ≤ 0.05 and **p b 0.01.
1768 F. Shaheen et al. / Biochimica et Biophysica Acta 1842 (2014) 1762–1769such as: Ubc 9, the sentrin-conjugated enzyme, predicted to regulate
GLUT4 and GLUT1 protein turnover; Daxx, the adapter protein associat-
ed with Fas; and the type II TGF-β receptors, which also binds GLUT4
(but not GLUT1) and may lead to GLUT4 SUMOlation. Interactions
of these proteins with GLUT C-terminus are also found to occurindependent of insulin. Other GLUT partners such as the aminopepti-
dase IRAP might regulate endosomal retention and regulate exocytosis
of GLUTs in the unstimulated state, either through static or dynamic re-
tentionwithin endosomes, therefore TERTmight play similar regulatory
roles in C2C12 cells.
1769F. Shaheen et al. / Biochimica et Biophysica Acta 1842 (2014) 1762–1769The physiological signiﬁcance of these ﬁndings may reside in the
changes that occur in TERT expression during ageing and cell senescence.
TERT activity decreases with age, resulting in telomere shortening. It is
well-established that impaired telomerase activity (and accompanying
reduction in telomere length) is strongly associated with the process of
ageing and senescence. In this context, it may be relevant that in various
models accelerated telomere shortening is also associatedwith insulin re-
sistance and type-2 diabetes [6–8]. Similarly, ageing is linked to increased
insulin resistance of which one of the main metabolic characteristics of
muscle is its loss of its ability to up-regulate glucose uptake in response
to insulin. Therefore, loss of TERT activity (e.g. in diabetes, ageing) and
insulin sensitivity of glucose uptake might occur in parallel. Our observa-
tionsmaypoint towards a potential link as TERT interactswith themolec-
ular machinery controlling glucose uptake. Our data may explain why
conditions of diminished TERT expression (associated with accelerated
telomere shortening) may also adversely affect glucose transport.
In conclusion, the present data identiﬁed a novel extra-nuclear
function of TERT mediated via association of TERT with GLUT proteins
to regulate glucose transport. Further studies will now focus on the
precise interactions of TERT with the insulin signalling cascade. These
ﬁndings might provide clues and possible mechanistic information for
the diminished insulin-responsiveness, with ageing, of glucose uptake
by muscle cells.
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